Brand-Boosting Schiff Nutrition Sees Upside In Top-Selling Supplements
This article was originally published in The Tan Sheet
Executive Summary
Schiff Nutrition CEO Tarang Amin, a veteran of managing brands for Clorox and P&G, sees additional upside in top-selling brands such as MegaRed and Move Free. The firm also is de-emphasizing its struggling private label business.
You may also be interested in...
NBTY Moves On From U.K. Health Food Retail Misadventure
Less than four years after acquiring U.K. chain Julian Graves as a platform for European growth, NBTY absorbs a $20 mil. charge to get rid of the subsidiary, which had “continuing operating losses.” NBTY plans to refocus resources on Holland & Barrett and its other European supplement retailers.
NBTY Moves On From U.K. Health Food Retail Misadventure
Less than four years after acquiring U.K. chain Julian Graves as a platform for European growth, NBTY absorbs a $20 mil. charge to get rid of the subsidiary, which had “continuing operating losses.” NBTY plans to refocus resources on Holland & Barrett and its other European supplement retailers.
Schiff Nutrition Enlists Airborne For Sortie Into Immune Support
The $150 million price represents more than twice Airborne’s approximately $70 million in annual net revenues for supplements marketed to strengthen immune support. The acquisition from GF Capital follows Pfizer’s recent foray into the immune support space by buying the maker of Emergen-C products.